Pharmacotherapy in patients with chronic coronary syndromes over a 20-year period (1997–2017)

Jankowski, Piotr; Kozieł, Paweł; Bogacki, Piotr; Gomuła, Piotr; Mirek-Bryniarska, Ewa; Nessler, Jadwiga; Podolec, Piotr; Bacquer, Dirk De; Backer, Guy De; Kotseva, Kornelia; Wood, D.; Czarnecka, Danuta; Kawecka‐Jaszcz, Kalina; Pająk, Andrzej

doi:10.33963/kp.15591

Cited by 3 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is strong scientific evidence that the long-term survival of coronary patients may be improved by providing optimal cardiovascular prevention [8]. The increasing proportion of obese patients may be responsible for the increase in hypertension, dyslipidemia, and diabetes prevalence as well as for insufficient improvement in the control of these risk factors despite increase in the drugs prescription rates in patients with coronary artery disease [4,13,22]. The present results urge to improve cardiovascular prevention in patients with coronary artery disease.…”

Section: Discussionmentioning

confidence: 75%

Obesity in patients with established coronary artery disease over a 20-year period (1997–2017)

Kozieł¹,

Jankowski²,

Mirek-Bryniarska³

et al. 2021

Polish Archives of Internal Medicine

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 75%

Obesity in patients with established coronary artery disease over a 20-year period (1997–2017)

Kozieł¹,

Jankowski²,

Mirek-Bryniarska³

et al. 2021

Polish Archives of Internal Medicine

Self Cite

View full text Add to dashboard Cite

“…Several previous studies have also shown that myocardial revascularization is not only more effective in reducing angina and the need for antianginal drugs, but also improves physical performance and quality of life compared to the conservative treatment strategy both in a short-and long-term follow-up [17,18]. However, the failure to properly implement lifestyle changes may contradict the benefits arising from the rapid development of pharmacological and invasive treatment of coronary artery disease observed in recent years [8,19,20]. The present analysis shows no significant improvement in the control of the main CAD risk factors and no significant change in the proportion of patients reporting the use of antiplatelets, β-blockers, and lipid-lowering drugs 6-18 months after discharge from the hospital.…”

Section: Discussionmentioning

confidence: 99%

Temporal changes in the secondary prevention of coronary artery disease in patients following myocardial revascularization

Kozieł

Jankowski

Surowiec

et al. 2020

pwki

Self Cite

View full text Add to dashboard Cite

Introduction Well-organized, effective secondary prevention of coronary artery disease (CAD) has a potential to improve the patients’ prognosis following myocardial revascularization procedures. Aim To evaluate overtime changes in the implementation of the ESC guidelines for secondary prevention by assessing control of the main risk factors and the rate of cardioprotective drug use in patients following myocardial revascularization procedures. Material and methods Patients aged < 81 years who had been hospitalized for a myocardial revascularization procedure in five hospitals serving Krakow and surrounding districts were recruited and interviewed 6–18 months following discharge. Their personal medical history, medication use and control of the main cardiovascular risk factors were evaluated using a standard questionnaire in 2006–2007, 2011–2013, and 2016–2017. The same five hospitals took part in surveys on each occasion. Results We examined 260 patients in 2006–2007, 200 in 2011–2013 and 190 in 2016–2017. We noted a significant difference in the management of surveys participants: 62% underwent percutaneous coronary intervention (PCI) and 38% coronary artery coronary artery bypass grafting (CABG) in 2006–2007 whereas the corresponding proportions in 2016–2017 were 90% and 10%. The proportion of patients who did not achieve target blood pressure (according to ESC guidelines valid at the time of each survey) in 2006–2007, 2011–2013 and 2016–2017 was 53.5%, 52.3%, and 38.9%, respectively, the proportion of those who did not achieve the LDL cholesterol target (according to ESC guidelines valid at the time of each survey) was 36.3%, 64.0%, and 61.7%, respectively, and the proportion of those with high fasting glucose was 12.6%, 14.6%, and 19.7%, respectively. The proportion of smokers was 16.2%, 19.5%, and 16.8%, whereas 30.5%, 28.6% and 40.5% of patients were obese in 2006–2007, 2011–2013 and 2016–2017, respectively. The proportion of patients taking antiplatelets (91.8% vs. 92.0% vs. 96.3%), β-blockers (90.3% vs. 87.5% vs. 92.6%), and lipid-lowering drugs (88.7% vs. 91.0% vs. 93.7%) did not change significantly. Conclusions: The analysis of three multicenter surveys provides evidence of the considerable potential for a further reduction in cardiovascular risk in patients following elective myocardial revascularization in Poland.

show abstract

“…Although the morbidity and case-fatality in acute myocardial infarction survivors has decreased over recent decades, mainly thanks to spread of pharmacological and invasive treatment methods, the decrease in cardiovascular risk is lower than one could expect based on the results of randomized trials of new therapies. This confusion could be partly explained on the basis of our results showing a gradual increase in central obesity prevalence which probably counteract the favorable changes in the management of CAD [ 10 ].…”

mentioning

confidence: 99%

Body mass index and waist circumference in patients with established coronary artery disease over a 20-year period

Jankowski

Kozieł²,

Pająk³

2023

Cardiol J.

View full text Add to dashboard Cite

show abstract

Pharmacotherapy in patients with chronic coronary syndromes over a 20-year period (1997–2017)

Cited by 3 publications

References 9 publications

Obesity in patients with established coronary artery disease over a 20-year period (1997–2017)

Obesity in patients with established coronary artery disease over a 20-year period (1997–2017)

Temporal changes in the secondary prevention of coronary artery disease in patients following myocardial revascularization

Body mass index and waist circumference in patients with established coronary artery disease over a 20-year period

Contact Info

Product

Resources

About